Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 4
2004 4
2005 5
2006 11
2007 10
2008 22
2009 6
2010 4
2011 11
2012 12
2013 11
2014 8
2015 3
2017 2
2018 3
2019 2
2020 4
2021 5
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Chang YH, Hajek J, Symeonides SN, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Gurney H, Chevreau C, Melichar B, Kopyltsov E, Alva A, Burke JM, Doshi G, Topart D, Oudard S, Hammers H, Kitamura H, Bedke J, Perini RF, Zhang P, Imai K, Willemann-Rogerio J, Quinn DI, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. N Engl J Med. 2021 Aug 19;385(8):683-694. doi: 10.1056/NEJMoa2106391. N Engl J Med. 2021. PMID: 34407342 Free article. Clinical Trial.
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
Powles T, Csőszi T, Özgüroğlu M, Matsubara N, Géczi L, Cheng SY, Fradet Y, Oudard S, Vulsteke C, Morales Barrera R, Fléchon A, Gunduz S, Loriot Y, Rodriguez-Vida A, Mamtani R, Yu EY, Nam K, Imai K, Homet Moreno B, Alva A; KEYNOTE-361 Investigators. Powles T, et al. Lancet Oncol. 2021 Jul;22(7):931-945. doi: 10.1016/S1470-2045(21)00152-2. Epub 2021 May 26. Lancet Oncol. 2021. PMID: 34051178 Clinical Trial.
Anti-angiogenic properties of microRNA-29a in preclinical ocular models.
Peng DW, Lan CL, Dong LQ, Jiang MX, Xiao H, D'Amato RJ, Chi ZL. Peng DW, et al. Among authors: d amato rj. Proc Natl Acad Sci U S A. 2022 Nov 8;119(45):e2204795119. doi: 10.1073/pnas.2204795119. Epub 2022 Nov 2. Proc Natl Acad Sci U S A. 2022. PMID: 36322719 Free PMC article.
Common polymorphisms in angiogenesis.
Rogers MS, D'Amato RJ. Rogers MS, et al. Among authors: d amato rj. Cold Spring Harb Perspect Med. 2012 Nov 1;2(11):a006510. doi: 10.1101/cshperspect.a006510. Cold Spring Harb Perspect Med. 2012. PMID: 23125197 Free PMC article. Review.
Forty-year journey of angiogenesis translational research.
Cao Y, Arbiser J, D'Amato RJ, D'Amore PA, Ingber DE, Kerbel R, Klagsbrun M, Lim S, Moses MA, Zetter B, Dvorak H, Langer R. Cao Y, et al. Among authors: d amato rj. Sci Transl Med. 2011 Dec 21;3(114):114rv3. doi: 10.1126/scitranslmed.3003149. Sci Transl Med. 2011. PMID: 22190240 Free PMC article. Review.
Angiogenesis and antiangiogenic therapy in endometriosis.
Becker CM, D'Amato RJ. Becker CM, et al. Among authors: d amato rj. Microvasc Res. 2007 Sep-Nov;74(2-3):121-30. doi: 10.1016/j.mvr.2007.04.008. Epub 2007 May 6. Microvasc Res. 2007. PMID: 17574280 Review.
The effect of genetic diversity on angiogenesis.
Rogers MS, D'Amato RJ. Rogers MS, et al. Among authors: d amato rj. Exp Cell Res. 2006 Mar 10;312(5):561-74. doi: 10.1016/j.yexcr.2005.10.021. Exp Cell Res. 2006. PMID: 16321383 Review.
Vaccine therapy for renal cancer.
Amato RJ. Amato RJ. Expert Rev Vaccines. 2008 Sep;7(7):925-35. doi: 10.1586/14760584.7.7.925. Expert Rev Vaccines. 2008. PMID: 18767943 Review.
125 results